Analyst Irina Rivkind Koffler works at LIFESCI and is focused on the Healthcare sector with 532 price targets and ratings documented since 2013 spanning on 2 stocks. Previously, Irina Rivkind Koffler worked at MIZUHO. Analyst's average stock valuation to be materialised ratio is 65.12% with an average time for price targets to be met of 243.94 days.
Most recent stock forecast was given on MNK, at 06-Aug-2019.
Irina Rivkind Koffler best performing recommendations are on DRRX (DURECT CORPORATION).
The best stock recommendation documented was for EGRX (EAGLE PHARMACEUTICALS, INC) at 1/9/2017. The price target of $64 was fulfilled within 2 days with a profit of $4.1 (6.02%) receiving and performance score of 30.1.
Average potential price target upside
Currently, out of the existing stock ratings of Irina Rivkind Koffler - 265 which are a Hold (41.93%), 323 which are a Buy (51.11%), 44 which are a Sell (6.96%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
32
$27.68 (640.74%)
3 months 24 days ago
0/1 (0%)
$27.96 (692.08%)
Buy
8
$2.62 (48.70%)
8
1 years 10 months 26 days ago
6/6 (100%)
$-12.28 (-61.00%)
371
Buy
2 years 10 months 4 days ago
2/2 (100%)
$1.77 (181.60%)
845
Buy
50
2 years 10 months 19 days ago
0/4 (0%)
$26.19 (112.85%)
Buy
30
$25.68 (594.44%)
30
7 years 9 months 7 days ago
5/5 (100%)
$5.16 (31.85%)
354
